|
Optimizing Patient Outcomes - Targeted Therapies for Thyroid Carcinoma |
1.00 |
03/14/2025 - 12:00am to 08/17/2025 - 12:00am |
|
Optimizing Patient Outcomes - New Primary Therapy Options for Stage III-IV Hodgkin Lymphoma |
1.00 |
04/24/2025 - 12:00am to 11/16/2025 - 12:00am |
|
Optimizing Patient Outcomes - Metastatic Castration-Resistant Prostate Cancer: Systemic Therapy Updates |
1.00 |
02/21/2025 - 12:00am to 07/20/2025 - 12:00am |
|
Newer Approaches to Treatment of Bladder Cancer |
1.00 |
06/15/2025 - 12:00am to 03/01/2026 - 12:00am |
|
New Tools for Breast Cancer Risk Assessment |
0.50 |
06/15/2025 - 12:00am to 03/01/2026 - 12:00am |
|
Neoadjuvant/Adjuvant Treatment of Early-Stage Breast Cancer with SABCS Updates |
1.25 |
03/15/2025 - 12:00am to 03/15/2026 - 12:00am |
|
NCCN Webinar Series - Optimizing Patient Outcomes: Collaborative Perspectives in Oncology |
|
01/07/2025 - 12:00am to 12/31/2025 - 12:00am |
|
NCCN Tumor Boards: Treatment Options and Navigating Sequencing of Therapies in Relapsed/Refractory Multiple Myeloma |
1.00 |
02/04/2025 - 12:00am to 08/10/2025 - 12:00am |
|
NCCN Tumor Boards: T-Cell Engager Therapy for Diffuse Large B-Cell Lymphoma: Bispecific Antibodies for Relapsed/Refractory Disease |
1.00 |
11/14/2024 - 12:00am to 07/13/2025 - 12:00am |
|
NCCN Tumor Boards: Skin Cancers Except Melanoma - Radiation Therapy Treatment Options |
1.00 |
06/18/2025 - 12:00am to 10/15/2025 - 12:00am |
|
NCCN Tumor Boards: New Approaches to the Management of Resectable Non-Small Cell Lung Cancer |
1.00 |
03/14/2025 - 12:00am to 08/31/2025 - 12:00am |
|
NCCN Tumor Boards - Exploring De-escalation of Radiation Therapy in the Management of Rectal Cancer |
1.00 |
06/24/2025 - 12:00am to 11/30/2025 - 12:00am |
|
NCCN Guidelines® Insights - Testicular Cancer, Version 2.2025 |
1.00 |
04/10/2025 - 12:00am to 04/10/2026 - 12:00am |
|
NCCN Guidelines® Insights - Survivorship, Version 2.2025 |
1.00 |
06/10/2025 - 12:00am to 06/10/2026 - 12:00am |
|
NCCN Guidelines® Insights - Survivorship, Version 2.2024 |
1.00 |
12/10/2024 - 12:00am to 12/10/2025 - 12:00am |
Facebook
Twitter
LinkedIn
Forward